Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sagimet Biosciences, Inc. Class A (SGMT)
:SGMT
RESEARCH TOOLSreports
Holding SGMT?
Track your performance easily
Sagimet Biosciences, Inc. Class A (SGMT) Ownership Overview
58.93% Insiders
6.11% Mutual Funds
0.42% Other Institutional Investors
3.88% ETFs
30.66% Public Companies and Individual Investors
The ownership structure of Sagimet Biosciences, Inc. Class A (SGMT) stock is a mix of institutional, retail, and individual investors. Approximately 10.41% of the company’s stock is owned by Institutional Investors, 58.93% is owned by Insiders, and 30.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 23, 2024 | George Kemble Ec,director | xxxxxxxxxxxxx | $43592 |
| Jul 23, 2024 | xxxxxxxxxxxxx | $25907 | |
| Jul 23, 2024 | Elizabeth Rozek Gc And Cco | xxxxxxxxxxxxx | $33724 |
| Mar 28, 2024 | David Happel President & Ceo,director | xxxxxxxxxxxxx | $63646 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,013,414 | Insider | 9.82% | 12,565,936 | |
| 3,011,575 | Insider | 9.82% | 12,558,268 | |
| 3,007,272 | Insider | 9.80% | 12,540,324 | |
| 3,000,275 | Insider | 9.78% | 12,511,147 | |
| 3,000,275 | Insider | 9.78% | 12,511,147 | |
| 2,031,118 | Insider | 6.62% | 8,469,762 | |
| 1,381,898 | Institution | 4.50% | 5,762,515 | |
| 1,093,678 | Institution | 3.57% | 4,560,637 | |
| 1,010,091 | Institution | 3.29% | 4,212,079 | |
| 639,200 | Insider | 2.08% | 2,665,464 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,010,091 | Institution | 3.29% | 4,212,079 | |
| 302,930 | Institution | 0.99% | 1,263,218 | |
| 185,000 | Institution | 0.60% | 771,450 | |
| 152,182 | Institution | 0.50% | 634,599 | |
| 138,300 | Institution | 0.45% | 576,711 | |
| 30,000 | Institution | 0.10% | 125,100 | |
| 15,559 | Institution | 0.05% | 64,881 | |
| 14,259 | Institution | 0.05% | 59,460 | |
| 8,961 | Institution | 0.03% | 37,367 | |
| 7,575 | Institution | 0.02% | 31,588 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 763,985 | Institution | 2.49% | 4,347,075 | |
| 329,693 | Institution | 1.07% | 1,875,953 | |
| 63,184 | Institution | 0.21% | 263,477 | |
| 20,638 | Institution | 0.07% | 85,751 | |
| 10,393 | Institution | 0.03% | 43,183 | |
| 1,776 | Institution | <0.01% | 7,379 |
FAQ
Who Owns Sagimet Biosciences, Inc. Class A (SGMT)?
According to the latest TipRanks data, approximately 0.42% of the company's stock is held by institutional investors, 58.93% is held by insiders, and 30.66% is held by retail investors.
What percentage of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.42% of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by institutional investors.
What percentage of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.66% of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by retail investors.
Who owns the most shares of Sagimet Biosciences, Inc. Class A (SGMT)?
Patrick Kerins owns the most shares of Sagimet Biosciences, Inc. Class A (SGMT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.